With the discovery of fi ve desmosomal genes harboring the mutations for ARVC, desmosomal disruption was proposed to be the major mechanism underlying the condition. But recent reports implicating the involvement of Wnt pathway and armadillo proteins in the process of fi bro-fatty replacement have given a new direction in understanding the etiology of the ARVC. [1] This study reports three novel mutations from Indian population in cardiac ryanodine receptor (RyR-2) and Pkp-2 genes. An intronic insertion was identifi ed in one patient in RYR2 gene. A missense mutation and a two base pair deletion in the N-terminal region were identifi ed in three patients. This study also describes the variability in expression of the condition in these probands.
Materials and Methods
This study included 34 patients diagnosed using the criteria proposed by Task Force of the European Society of Cardiology/International Society and Federation of Cardiology [2] and 100 control individuals selected based on the absence of history/family history of any cardiac disorder.
An informed consent was obtained from all the individuals participating in this study, and Institutional ethics committee approval from Care Hospitals Hyderabad has been obtained for clinical and genetic analyses. Diagnosis was based on 12-lead surface electrocardiograph (ECG), cardiac Doppler Echo, and history of familial condition.
For genetic analysis, DNA was isolated by rapid nonenzymatic method [3] from whole blood. All the exons of Pkp-2, DSC-2, DSG-2, and JUP genes along with regulatory and promoter regions of TGF-3 gene, exons coding for FKBP binding domain of RyR-2 gene, and N-terminal region of Dsp were screened for mutations.
The primer sequences for Pkp-2, JUP, DSC2, DSG-2, and TMEM43 genes were obtained from Gerull et al., [4] Whittock et al., [5] Syrris et al., [6] Awad et al., [7] and Merner et al., [8] respectively. For amplifi cation of regulatory regions of transforming growth factor -3 and exons of RyR2 and Dsp, genes were taken from http://telethon. bio.unipd.it/ARVDnet/molgen_arvd8.html.
The amplified polymerase chain reaction (PCR) products were screened by single-strand conformation polymorphism (SSCP) for any variation in the sequence.
The amplifi ed PCR products with abnormal band pattern were purifi ed using GeNei TMQuick PCR Purifi cation Kit (Bangalore, India) and sequenced commercially (SolGent Co., Ltd., South Korea) using ABI 3730XL capillary DNA Sequencer (50 cm capillary).
Results

Genetic screening
Screening of the previously implicated nondesmosomal gene segments, namely, regulatory regions of TGF-3 and exon-10 of TMEM43 did not reveal any mutations, but a polymorphism in 5 UTR (c) region of TGF-3 gene was identifi ed [ Table 1 ].
Mutational screening of exons coding for FKBP binding domain of RyR-2 which was proposed to be involved in pathogenesis of ARVC revealed an abnormal pattern in a patient and sequencing revealed an insertion of a base "G" (2487896_248797 ins G)
[ Figure 1 ] 30 bp downstream the coding region of exon-28
[ Table 2 ]. Affect of this insertion mutation on splicing was analyzed using in silico splice site prediction software (http://www.fruitfly.org/cgi-bin/seq _tools /splice.pl)
[ Figure 2 ] which revealed a formation of a cryptic splice are reported in failing hearts [9] and hence, the insertion mutation in exon-28 coding for SPRY domain might alter interdomain interactions thereby leading to heart failure, which is reported in ARVC.
Screening of desmosomal genes Dsp, JUP, desmsocollin-2, and DSG-2 do not reveal any patient-specifi c pathogenic mutations, but novel and known polymorphisms were identifi ed [ Table 1 ]. [ Table 2 ]. On screening the family members, both the daughters of P-1 were found to be carriers of the same mutation. Relatives of P-2 were unavailable for this study.
Mutation screening of desmosomal gene
Because identical mutation was identifi ed in two patients, haplotype analysis was carried out to determine the origin of the mutation. Four repeat markers spanning 300,000 bp including the entire Pkp-2 gene were analyzed in both the patients and relatives of P-1. Primer sequences for these markers were obtained from van Tintelen et al. [10] The phase of P-1 was determined based on the analysis on three fi rst-degree relatives. The chromosome containing the haplotype shared by both the carriers and patient possessed the deletion.
Comparison of the haplotypes of both the patients shows that the mutation may have originated independently. Haplotype of all the typed individuals is given in [ Figure 4 ].
In addition, one patient showed an abnormal band pattern in exon-3.2 of Pkp-2 gene and sequencing revealed a heterozygous C792T missense change leading to P>L substitution at 244 th amino acid position [ Table 2 ]. This amino acid falls in the amino terminal region preceding the armadillo repeats. It has been reported earlier by Chen et al. [11] that N-terminal region of Pkp-2 is essential in promoting the interactions with other desmosomal components, namely, JUP, Dsp, desmoglein, and desmocollin isoforms and more importantly this region is critical for localization of Pkp-2 to the cell borders. Further, N-terminal region has also been implicated in signaling functions through its interaction with the -catenin and upregulating the -catenin/T-cell factor signaling activity.
Clinical investigations
Clinically the patient harboring RyR-2 gene mutation suffered from symptoms of dyspnea and presyncope during physical strain, an episode of syncope and swelling of limbs for the past 6-7 years and was diagnosed with ARVC at the age of 55 years. ECG evaluation revealed sinus bradycardia and low-voltage QRS complexes with QRS transition being less than/ equal to V1. Repolarization abnormalities in the precordial leads with T-wave inversion beyond lead-V3 along with atrial fi brillation were also observed. 2D Doppler ECHO revealed dilatation and thinning out of right ventricular free wall with evidence of scarring on profusion imaging. This patient satisfi ed two major and two minor criteria [ Table 3 ].
The clinical profile of two patients (P-1 and P-2) harboring same Pkp-2 gene mutation in exon-3.1 was analyzed. Patient P-1 was a 29-year-old woman, presented with symptoms such as dyspnoea, palpitations, chest pain, presyncope, and syncope with occasional swelling of limbs, while patient P-2 was a 32-year-old man, suffering from palpitations and presyncope.
Twelve-lead ECG of patient P-1 revealed normal sinus rhythm with heart rate of 60 bpm. There was a left axis deviation with left anterior hemiblock. There was also an epsilon wave in lead V1 with poor progression of R waves voltage in precordial leads. T-wave inversion was observed from leads V1 to V6 with low overall QRS voltage (in all 12 leads). ECG of patient P-2 also revealed normal sinus rhythm and heart rate of 60 bpm. There was a right axis deviation with right posterior hemiblock. There was an epsilon wave in lead V1 RBBB and upright R waves from leads V1 to V6 with small QR in lead V1. T-wave inversion was observed from leads V1 to V6 [ Table 3 ].
Cardiac Echo Doppler of patient P-1 revealed a dilated right ventricle with hypokinetic right ventricular apex, adjoining free wall with an apical clot and RV dysfunction. The mid-segment free wall of RV was also hypokinetic with normal LV function. In contrast to P-1, RV of patient P-2 was only mildly dilated. This patient showed good RV free wall motion and normal LV function. Therefore, patient P-1 showed RV dysfunction with structural alterations and also conduction abnormalities, thereby fulfi lling two major criteria for diagnosis. Further the two minor criteria of inverted T waves and family history of premature sudden death (<35 years) were also fulfi lled. Patient P-2 showed depolarization abnormalities and also repolarization abnormalities along with mild RV dilation, thereby fulfi lling one major and two minor criteria. Two fi rst-degree relatives of patient P-1 (both daughters) were available for further analysis. Twelve-lead ECG and Cardiac Echo Doppler showed no abnormalities.
Clinically the patient with missense mutation in exon-3.2 of Pkp-2 gene was a 28-year-old man suffering with symptoms palpitations and presyncope with an average frequency of four episodes per week. A 12-lead ECG revealed a heart rate of 75 bpm with sinus rhythm and a QRS duration of 0.12 ms with left axis deviation. T-wave inversions in anterior leads V2-V3 and right bundle branch block morphology were also observed. 2D Doppler ECHO revealed conserved RV dimensions with normal systolic function, and RV morphology showed dyskinesis and right atrial enlargement. Hence, fulfi lling three major and one minor standardized criteria [ Table 3 ].
Discussion
ARVC is a rare form of cardiomyopathy, with an estimated prevalence of 1 in 5000. [12] Initial reports of ARVC are from Italian population, followed by American and now from Asian populations with mutations in similar genes underlying the condition, which underscore the signifi cance of the pathogenic mechanism in maintaining the functional myocardium. This study, carried out for the Table 3 ].
Family history of P-1 had the patient's mother dying suddenly at the age of 25 years without any known cause.
Although with earlier studies that have shown wide spectrum of expression even within the family members carrying the same mutation. [13] A study with monozygotic twins has also shown variability in expression implicating environmental factors as major triggers for the progression. [14] Therefore, specifi c genotype-based triggers need to be identifi ed to prevent the severity of the progression.
The third variation in Pkp-2 gene, a missense mutation C792T that would result in P244L, affects N-terminal region of the protein, which is involved in regulatory activities such as desmosomal formation and catenindependant Wnt pathway modulation. So any substitution in this region causes disturbances in the various proteinprotein interactions.
Conclusion
ARVC is a prevalent cardiomyopathy in Indian population. Our study identifi ed novel genetic variants (both mutations and polymorphisms) in the already implicated genes for ARVC, hence emphasizes the high genetic diversity of our population and advocates the inclusion of our population in international populationbased genotypic estimation and data base studies.
Drawbacks
Experimentally, the mutation detection was based on the band pattern variation using SSCP technique, which is not a very sensitive. Further transcript and protein expression analyses were not performed to understand the affect of the mutations identifi ed.
